Practical Guidance for Voxelotor in sickle cell disease
Voxelotor is a well-tolerated oral agent in the era of multiple disease modifying agents for sickle cell disease.
United States Institute For Economic Medication Administration Drug Administration Federal Drug Administration Clinical Review
Source: dovepress.com